November 10, 2016 / 11:07 PM / 10 months ago

BRIEF-Nuvo Pharmaceuticals reports Q3 revenue of C$5.5 million

Nov 10 (Reuters) - Nuvo Pharmaceuticals Inc :

* Nuvo Pharmaceuticals Inc - net income from continuing operations for Q3 of 2016 was $1.3 million compared to $2.1 million

* Nuvo anticipates signing licensing agreements of pennsaid 2pct covering multiple countries beginning in 2017

* Nuvo Pharmaceuticals announces 2016 third quarter results

* Q3 revenue C$5.5 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below